Mobic (Meloxicam)

Meloxicam, the active ingredient in Mobic, is a NSAID (Oxicam) presented as an injection for intramuscular use. It treats osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain and post‑operative pain in adults.

GNH USA supplies Mobic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is used to manage inflammatory and painful conditions associated with musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and inflammation, improving mobility. - Rheumatoid arthritis: alleviates chronic joint inflammation and swelling. - Acute musculoskeletal pain: provides rapid relief of pain following injury or strain. - Post‑operative pain: controls pain and inflammation after surgical procedures.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache or dizziness. - Injection‑site reactions: erythema, swelling, or mild pain. - Mild skin rash. - Transient elevation of liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury. - Hepatotoxicity with marked liver enzyme rise. - Cardiovascular events including myocardial infarction. - Anaphylactic or severe hypersensitivity reactions.

Before initiating meloxicam therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Assess renal function: check creatinine and eGFR prior to and during treatment. - Evaluate hepatic status: monitor liver enzymes in patients with liver disease. - Review cardiovascular risk: use cautiously in patients with history of heart disease. - Avoid use in patients with active peptic ulcer disease or gastrointestinal bleeding. - Use the lowest effective dose for the shortest duration needed. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - Lithium: meloxicam may raise lithium serum levels, risking toxicity. - Methotrexate: reduced clearance may lead to methotrexate toxicity. - ACE inhibitors or ARBs: may worsen renal function when combined.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced renal perfusion. - SSRIs or SNRIs: heightened bleeding risk. - Corticosteroids: increased gastrointestinal ulcer risk. - Cyclosporine: possible additive nephrotoxicity. - Digoxin: may increase serum digoxin concentrations.